Search research articles
Contact Us
Filters
Showing results (701-710 of 751) with videos related to
Page
of 76
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
March 31, 2019
Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene-drug pairs across ambulatory care settings
Emily J Cicali, Kristin Wiisanen Weitzel, Amanda R Elsey, et al.
Biological Psychiatry
|
March 14, 2021
Investigating Shared Genetic Basis Across Tourette Syndrome and Comorbid Neurodevelopmental Disorders Along the Impulsivity-Compulsivity Spectrum
Zhiyu Yang, Hanrui Wu, Phil H Lee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 11, 2017
SU9516 Increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy
Apurva Sarathy, Ryan D Wuebbles, Tatiana M Fontelonga, et al.
Behavior Genetics
|
April 3, 2010
Symptom dimensions in OCD: item-level factor analysis and heritability estimates
Hilga Katerberg, Kevin L Delucchi, S Evelyn Stewart, et al.
Scientific Reports
|
September 26, 2015
High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations
Bryan T Mott, Richard T Eastman, Rajarshi Guha, et al.
Cancer Research
|
January 19, 2018
Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAF
Wenlin Shao, Yuji M Mishina, Yun Feng, et al.
Oncotarget
|
October 27, 2015
Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma
Dominik Bogen, Jun S Wei, David O Azorsa, et al.
Science (New York, N.Y.)
|
October 15, 2005
Sequence variants in SLITRK1 are associated with Tourette's syndrome
Jesse F Abelson, Kenneth Y Kwan, Brian J O'Roak, et al.
Cancer
|
December 8, 2016
Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study
Abigail D Winder, Kruti P Maniar, Jian-Jun Wei, et al.
NPJ Precision Oncology
|
January 4, 2025
Cyclin E1/CDK2 activation defines a key vulnerability to WEE1 kinase inhibition in gynecological cancers
Daehwan Kim, Heekyung Chung, Wen Liu, et al.
Page
of 76
Search research articles
Search
Showing results (701-710 of 751) with videos related to
Sort By:
Page
of 76
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
March 31, 2019
Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene-drug pairs across ambulatory care settings
Emily J Cicali, Kristin Wiisanen Weitzel, Amanda R Elsey, et al.
Biological Psychiatry
|
March 14, 2021
Investigating Shared Genetic Basis Across Tourette Syndrome and Comorbid Neurodevelopmental Disorders Along the Impulsivity-Compulsivity Spectrum
Zhiyu Yang, Hanrui Wu, Phil H Lee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 11, 2017
SU9516 Increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy
Apurva Sarathy, Ryan D Wuebbles, Tatiana M Fontelonga, et al.
Behavior Genetics
|
April 3, 2010
Symptom dimensions in OCD: item-level factor analysis and heritability estimates
Hilga Katerberg, Kevin L Delucchi, S Evelyn Stewart, et al.
Scientific Reports
|
September 26, 2015
High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations
Bryan T Mott, Richard T Eastman, Rajarshi Guha, et al.
Cancer Research
|
January 19, 2018
Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAF
Wenlin Shao, Yuji M Mishina, Yun Feng, et al.
Oncotarget
|
October 27, 2015
Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma
Dominik Bogen, Jun S Wei, David O Azorsa, et al.
Science (New York, N.Y.)
|
October 15, 2005
Sequence variants in SLITRK1 are associated with Tourette's syndrome
Jesse F Abelson, Kenneth Y Kwan, Brian J O'Roak, et al.
Cancer
|
December 8, 2016
Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study
Abigail D Winder, Kruti P Maniar, Jian-Jun Wei, et al.
NPJ Precision Oncology
|
January 4, 2025
Cyclin E1/CDK2 activation defines a key vulnerability to WEE1 kinase inhibition in gynecological cancers
Daehwan Kim, Heekyung Chung, Wen Liu, et al.
Page
of 76